Abstract: (EN)A fragrance composition comprising one or more musk or fragrance accords for use in reducing or inhibiting a subject"s physiological reaction to stress. The composition can be incorporated into consumer products.
1. A fragrance composition comprising at least one musk accord, wherein the musk accord comprises at least one musk compound selected from the group consisting of l-(3,3-dimethylcyclohexyl)ethyl acetate, ((12E)-l-oxacyclohexadec-12-en-2-one), 17-oxacycloheptadec-6-en-l-one, L-Muscone, 3-methyl-5-((lR)-2,2,3-trimethylcyclopentyl)pentan-2-one, l-(l,l,2,3,3,6-hexamethyl-2H-inden-5-yl)ethanone, ((E)-2-methyl-4-(2,2,3-trimethyl-l-cyclopent-3-enyl)but-2-en-l-ol), and combinations thereof, wherein the musk accord is present in an amount of from about 1% to about 100% by weight of the fragrance composition.
2. The fragrance composition of claim 1, wherein the musk accord is present in an amount of at least about 5% w/w.
3. The fragrance composition of any of the preceding claims, wherein the musk accord is present in an amount of at least about 10% w/w.
4. The fragrance composition of any of the preceding claims, wherein the musk accord is present in an amount of at least about 20% w/w.
5. A consumer product comprising the fragrance composition of any one of claims 1-4.
6. The consumer product of claim 5, wherein the consumer product comprises a sufficient amount of the at least one musk accord to provide a concentration of said at least one musk of at least 7 nanograms per cubic foot of air, preferably from about 7.4 nanograms per cubic foot of air to about 28 nanograms per cubic foot of air, more preferably 7.4 nanograms per cubic foot of air to about 27.7 nanograms per cubic foot of air, said consumer product being a hair removal, sexual health care, fine fragrance and/or pet care product.
7. The consumer product of any one of claims 5-6, said consumer product comprising, in addition to said at least one musk accord, one or more fragrance raw materials.
8. A consumer product according to any one of claims 5-7, further comprising an ingredient selected from the group consisting of bleach activators, hydrogen peroxide, perfumes, fragrance delivery systems, carriers, structurants, solvents, and mixtures thereof.
9. A method of reducing or inhibiting a stress response in a subject in need thereof comprising: administering the fragrance composition of any one of claims 1-4 to the subject in an amount effective to reduce or inhibit a response to stress stimuli.
10. The method of claim 9, wherein the fragrance composition is administered before, during, or after exposure to the stress stimuli.
| # | Name | Date |
|---|---|---|
| 1 | 201847002602-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [23-01-2018(online)].pdf | 2018-01-23 |
| 2 | 201847002602-STATEMENT OF UNDERTAKING (FORM 3) [23-01-2018(online)].pdf | 2018-01-23 |
| 3 | 201847002602-PROOF OF RIGHT [23-01-2018(online)].pdf | 2018-01-23 |
| 4 | 201847002602-PRIORITY DOCUMENTS [23-01-2018(online)].pdf | 2018-01-23 |
| 5 | 201847002602-POWER OF AUTHORITY [23-01-2018(online)].pdf | 2018-01-23 |
| 6 | 201847002602-FORM 1 [23-01-2018(online)].pdf | 2018-01-23 |
| 7 | 201847002602-DRAWINGS [23-01-2018(online)].pdf | 2018-01-23 |
| 8 | 201847002602-DECLARATION OF INVENTORSHIP (FORM 5) [23-01-2018(online)].pdf | 2018-01-23 |
| 9 | 201847002602-COMPLETE SPECIFICATION [23-01-2018(online)].pdf | 2018-01-23 |
| 10 | 201847002602-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [23-01-2018(online)].pdf | 2018-01-23 |
| 11 | Correspondence by Agent_Assignment_05-02-2018.pdf | 2018-02-05 |
| 12 | 201847002602-FORM 3 [29-05-2018(online)].pdf | 2018-05-29 |
| 13 | 201847002602-FORM 3 [05-06-2018(online)].pdf | 2018-06-05 |
| 14 | 201847002602-FORM 18 [16-01-2019(online)].pdf | 2019-01-16 |
| 15 | 201847002602-FER.pdf | 2019-10-23 |
| 1 | searchstrategy_23-10-2019.pdf |